MRI sensor to change oxygen monitoring
A new MRI sensor could change the way oxygen is monitored in the body and aid cancer diagnosis and treatment. Low oxygen environments allow cancer cells to thrive with tumours tending to be more resistant to therapy and metastasising more aggressively. Lack of a reliable and non-invasive way to make measurements led MIT researchers to develop an injectable device that can be left in the body for extended periods of time. The sensor is made of two types of silicone, one to provide the MRI signal, and another to offer structural support. It combines PDMS and DDMPS, which has an oily consistency and can be dissolved in PDMS to give a swollen polymer. Researchers shaped this into a 1.5mm sensor that could be implanted during a biopsy. They also developed smaller particles that could be injected through a needle and clump together to form a solid sensor. DDMPS absorbs molecular oxygen which alters the spin of protons in silicon and can be detected by MRI. Measuring the shift in the MRI signal reveals how much oxygen is present and could enable doctors to track the state of a tumour and predict how it might respond to radiation treatment.
The device can also be created as a suspension of microparticles that are injected into the body, where they clump together. In this image, the particles are suspended in saline before injection. Credit Vincent Liu and Jay Sy.